/Companies

Axion BioSystems

Atlanta, US · Delaware corporation · 127 employees on LinkedIn · 1 known investors

Find your way into Axion BioSystems

Sign up to find every way you can get introduced to Axion BioSystems

  • Your email: who you already know at Axion BioSystems, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Axion BioSystems team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

JR
JAMES ROSSDirector, President and Chief Technical Officer
TJ
THOMAS J. O'BRIENDirector, Chief Executive Officer

Board

GE
GLENN EPSTEINBoard director
DG
DAVID GIBSONBoard director

Investors · 1

McKinsey & Companyreported

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$14.3M disclosed across 2 rounds · 2016–2018

▶$8MraisedOct 2018 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES ROSSExecutive Officer, Director
  • JAY TEICHDirector
  • DAVID GIBSONDirector
  • THOMAS J. O'BRIENExecutive Officer, Director
  • MICHELLE JARRARDDirector
  • GLENN EPSTEINDirector
Offering amount
$8M
Amount sold
$8M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.3MraisedMay 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • THOMAS J. O'BRIENExecutive Officer, Director
  • GLENN EPSTEINDirector
  • DAVID GIBSONDirector
  • JAMES ROSSExecutive Officer, Director
Offering amount
$6.3M
Amount sold
$6.3M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Axion BioSystems went on to found or lead other companies.

Acquisitions · 1

Early investors' stakes continue via these deals
Cytotronics

Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system. It serves cell biologists working in therapeutic areas such as vascular biology, stem cell differentiation, cardiovascular and neurological disease, and oncology.

Frequently asked questions

Who founded Axion BioSystems?
Axion BioSystems was founded by JAMES ROSS.
Who are Axion BioSystems's investors?
Axion BioSystems's investors include McKinsey & Company.
How much funding has Axion BioSystems raised?
Axion BioSystems has disclosed $14.3M raised across 2 rounds.
Where is Axion BioSystems headquartered?
Axion BioSystems is headquartered in Atlanta, US.